文献速递头颈部肿瘤放疗放疗物理与技术

头颈部肿瘤患者放疗专用硬件装置PET/MRI的图像质量评估

Assessment of image quality of a radiotherapy-specific hardware solution for PET/MRI in head and neck cancer patients.
PubMed 文献 · Radiother Oncol · 2018-05-07

本研究纳入10例头颈部肿瘤患者,在放疗前分别以放疗体位和诊断体位行同步PET/MRI,评估放疗专用体位固定装置的可行性并配对比较图像质量。结果显示放疗体位PET/MRI临床可行,PET与MR肿瘤轮廓的平均对称表面距离分别为0.6 mm和0.9 mm,T2加权MRI信噪比降低-26.2%,平均ADC值无显著差异,作者认为放疗体位图像质量满足放疗计划要求。

要点

  • 10例头颈部肿瘤患者均成功完成放疗体位同步PET/MRI检查,证实临床可行。
  • PET与MR肿瘤轮廓的平均对称表面距离中位数分别为0.6 mm和0.9 mm。
  • 放疗体位T2加权MRI信噪比降低-26.2%,平均ADC值无显著差异。

核心结论

  • 使用放疗体位固定装置的头颈部肿瘤患者同步PET/MRI临床可行,尽管信噪比降低,放疗体位获得的图像质量满足放疗计划要求,数据可用于个体化放疗计划。

研究设计与样本

  • 10例头颈部肿瘤患者在治疗前分别以放疗体位和诊断体位行同步PET/MRI检查。
  • 通过配对图像分析比较两种体位的18F-FDG-PET、T1/T2加权和扩散加权MRI图像质量。
  • 图像质量评估采用PET和MR肿瘤轮廓的平均对称表面距离、MR信噪比和平均表观扩散系数值。

主要发现

  • 放疗体位PET/MRI可行,所有患者均成功完成检查。
  • PET和MR轮廓的平均对称表面距离(中位数/范围)分别为0.6(0.4-1.2)mm和0.9(0.5-1.3)mm。
  • 放疗体位T2加权MRI信噪比降低-26.2%(-39.0至-11.7)。
  • 平均ADC值无显著差异。

关键数值与推荐

  • PET轮廓平均对称表面距离中位数0.6 mm,范围0.4-1.2 mm。
  • MR轮廓平均对称表面距离中位数0.9 mm,范围0.5-1.3 mm。
  • 放疗体位T2加权MRI信噪比变化-26.2%,范围-39.0至-11.7。

临床怎么用

  • 作者认为放疗体位同步PET/MRI获得的图像质量满足放疗计划要求,数据可用于个体化放疗计划。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Functional PET/MRI has great potential to improve radiotherapy planning (RTP). However, data integration requires imaging with radiotherapy-specific patient positioning. Here, we investigated the feasibility and image quality of radiotherapy-customized PET/MRI in head-and-neck cancer (HNC) patients using a dedicated hardware setup. MATERIAL AND METHODS: Ten HNC patients were examined with simultaneous PET/MRI before treatment, with radiotherapy and diagnostic scan setup, respectively. We tested feasibility of radiotherapy-specific patient positioning and compared the image quality between both setups by pairwise image analysis of 18F-FDG-PET, T1/T2-weighted and diffusion-weighted MRI. For image quality assessment, similarity measures including average symmetric surface distance (ASSD) of PET and MR-based tumor contours, MR signal-to-noise ratio (SNR) and mean apparent diffusion coefficient (ADC) value were used. RESULTS: PET/MRI in radiotherapy position was feasible - all patients were successfully examined. ASSD (median/range) of PET and MR contours was 0.6 (0.4-1.2) and 0.9 (0.5-1.3) mm, respectively. For T2-weighted MRI, a reduced SNR of -26.2% (-39.0--11.7) was observed with radiotherapy setup. No significant difference in mean ADC was found. CONCLUSIONS: Simultaneous PET/MRI in HNC patients using radiotherapy positioning aids is clinically feasible. Though SNR was reduced, the image quality obtained with a radiotherapy setup meets RTP requirements and the data can thus be used for personalized RTP.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Winter RM, Leibfarth S, Schmidt H, et al. Assessment of image quality of a radiotherapy-specific hardware solution for PET/MRI in head and neck cancer patients. Radiother Oncol. 2018. PMID: 29747873. doi:10.1016/j.radonc.2018.04.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。